Skip to content

Problem management plus (PM+) intervention for depression in adolescents: an efficacy and mechanism study

A randomized controlled study of the effectiveness and efficacy mechanisms of a problem management intervention (PM+) for depressive disorders in adolescents

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060409
Enrollment
Unknown
Registered
2022-05-31
Start date
2022-05-19
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

control group:Enhanced conventioal therapy
experimental group:PM+ psychological therapy intervention

Sponsors

Shenzhen Kangning Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Hospital inclusion criteria: (1) Aged 12-18 years, years of education >=5 years; (2) Meet the diagnostic criteria for major depressive disorder of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); (3) Use MINI screening to exclude other mental disorders; (4) Subjects and their families agree to participate in the program and sign informed consent. 2. School inclusion criteria: (1) PHQ-9>=5, but did not meet the DSM-5 diagnostic criteria for depression; (2) Aged 12-18 years; (3) Years of education >= 6 years; (4) No previous history of mental disorders; (5) Subject and family members agree to participate in the program and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe physical diseases (such as cardiovascular, liver, kidney, gastrointestinal diseases, etc.), infectious diseases and immune system diseases; 2. Patients with traumatic brain injury, epilepsy or other known severe neurological diseases or organic brain diseases; 3. Patients with a history of severe mental disorders such as schizophrenia or mental retardation; 4. Dependent on or abusing alcohol or other substances or taking antipsychotics, central stimulants, etc.; 5. Patients at high risk of suicide; 6. Patients with contraindications for MRI examination, such as pregnant or lactating women, or those planning to become pregnant, patients with cardiac pacemakers, patients with aneurysm clips after cranial surgery, patients with ferromagnetic implants, patients with artificial metal valves after cardiac surgery, patients with alloy prostheses or metal joints, patients with insulin pumps or nerve stimulators in the body, etc.; 7. Patients with contraindications for EEG examination.

Design outcomes

Primary

MeasureTime frame
Depression severity;Non-suicidal self-injury behavior;Suicidal ideation;Rumination;Functional magnetic resonance imaging;EEG;

Secondary

MeasureTime frame
Childhood trauma;Self dignity;Emotion regulation;Recognition;Depression external appearance;

Countries

China

Contacts

Public ContactZhou Yongjie

Shenzhen Kangning Hospital

qingzhu1108@126.com+86 13927416401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026